Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

Abstract
No abstract available
Funding Information
  • Janssen Research and Development

This publication has 33 references indexed in Scilit: